To describe the incidence of cardiovascular risk factors, or race-related disparities in incidence, across the age spectrum in adults. DESIGN: Longitudinal cohort. SETTING: National sample. PARTICIPANTS: Community-dwelling black and white adults recruited between 2003 and 2007. MEASUREMENTS: Incident hypertension, diabetes mellitus, dyslipidemia and atrial fibrillation over 10 years of follow-up in 10,801 adults, stratified according to age (45-54, 55-64, 65-74, ≥75). RESULTS: There was no evidence (P ≥ .68) of an agerelated difference in the incidence of hypertension for white men (average incidence 38%), black men (48%), or black women (54%), although for white women incidence increased with age (45-54, 27%; ≥75, 40%). Incidence of diabetes mellitus was lower at older ages for white men (45-54, 15%; ≥75, 8%), black men (45-54, 29%; ≥75, 13%), and white women (45-54, 11%; ≥75, 4%), although there was no evidence (P = .11) of age-related changes for black women (average incidence 21%). For dyslipidemia, incidence for all race-sex groups was approximately 20% for aged 45 to 54 but approximately 30% for aged 54 to 64 and 65 to 74 and approximately 22% for aged 75 and older. Incidence of atrial fibrillation was low at age 45 to 54 (<5%) but for aged 75 and older was approximately 20% for whites and 11% for blacks. The incidence of hypertension, diabetes mellitus, and dyslipidemia was higher in blacks across the age spectrum but lower for atrial fibrillation. CONCLUSION: Incidence of risk factors remains high in older adults. Blacks have a higher incidence of hypertension, diabetes mellitus, and dyslipidemia after age 45, underscoring the ongoing importance of prevention of all three conditions in mid-to later life. J Am Geriatr Soc 65: 83-90, 2017. 
A merican blacks have a high prevalence of many of the most potent cardiovascular disease (CVD) risk factors, particularly hypertension and diabetes mellitus, 1,2 which has been suggested is a major contributor to the higher risk of CVD disease in blacks. In the Multiple Risk Factor Intervention Trial (MRFIT), disparities in the prevalence of risk factors explained 34% of the disparity in CVD risk between blacks and whites. 3 More recently, the REasons for Geographic And Racial Differences in Stroke (REGARDS) study reported that approximately 40% of the disparity in incident stroke was attributable to the prevalence of "traditional" risk factors and uncontrolled blood pressure. 4 In addition, blacks have twice the risk of acute death from coronary heart disease, a risk almost entirely attributable to higher prevalence of risk factors in blacks. Strategies for CVD prevention include primordial prevention of the development of CVD risk factors, primary prevention to control risk factors once developed, and secondary prevention to prevent recurrence after CVD events. [6] [7] [8] [9] It has long been recognized that blacks have a much younger onset of risk factors. 10, 11 Primordial prevention efforts have traditionally been targeted at younger populations, 6, [12] [13] [14] [15] with clinical attention naturally shifting to control of prevalent risk factors at older ages. Although some falsely consider primordial risk factor prevention as an effort to be targeted only at young people, researchers and people in the healthcare delivery system promoting the value of primordial prevention [6] [7] [8] [9] and the recently passed Patient Protection and Affordable Care Act consider risk factor prevention to be a "life course" effort. Although the incidence of risk factors continues in older age groups, there are few contemporary data on the incidence of CVD risk factors in older black and white adults. [16] [17] [18] The primary objective of this study was to quantify the incidence of, and contrast the black-white differences in, CVD risk factors in older adults, including hypertension, diabetes mellitus, hyperlipidemia, and atrial fibrillation.
METHODS
The REGARDS study recruited 30,239 community-dwelling participants between January 2003 and October 2007. Participants were selected from commercial lists and recruited through a combination of mail and telephone contact. Because of a focus on geographic and racial disparities in stroke mortality, blacks were oversampled (44%), as were residents of the southeastern U.S. Stroke Belt states (56%). The Stroke Belt states were defined as North Carolina, South Carolina, Georgia, Tennessee, Alabama, Mississippi, Arkansas, and Louisiana, with the remaining 44% of the participants selected from the remaining 40 contiguous U.S. states. Eligibility criteria includes non-Hispanic black or white race, aged 45 and older, absence of conditions associated with a life expectancy of less than 5 years, and not being in or on a waiting list for a nursing home. Participation rate was estimated as 33%, similar to other studies. For those agreeing to participate, the telephone interviewers conducted an interview to assess CVD risk factors and medical history. An in-person assessment for direct measurement of risk factors (blood pressure, anthropomorphic characteristics, electrocardiogram) and collection of blood and urine samples was conducted after the interview. Participants were followed at 6-month intervals to detect suspected cardiovascular events. Details of the study design are provided elsewhere. 19 Starting in April 2013, participants were invited to undergo a second in-person risk factor assessment using a similar protocol approximately 10 years after the baseline. Through April 2015, 17,187 participants were invited, and 14,983 (87%) telephone-administered risk factor assessments were completed, with 2,045 (12%) participants declining participation in the second assessment. In the 14,983 participants who agreed to participate, 10,801 (72%) in-person assessments have been performed. All participants provided signed informed consent at baseline and follow-up visits. The institutional review boards of all participating universities approved the study.
Incidence of hypertension, diabetes mellitus, dyslipidemia and atrial fibrillation was assessed because they are major risk factors for heart disease and stroke but are not associated with a high short-term mortality, so participants with an incident condition would be likely to survive for reassessment of risk factors. Hypertension, diabetes mellitus, and dyslipidemia are well-established risk factors for heart disease, 1 with recent evidence that atrial fibrillation is also an important risk factor for incident heart disease. 20 Hypertension, diabetes mellitus, and atrial fibrillation are also major risk factors for stroke. 21 Dyslipidemia is a major risk factor for heart disease. 1 With the focus on incident risk factors, participants with prevalent heart disease and stroke were included in the analysis because they are also at risk of developing new incident risk factors. Each of the CVD risk factors was defined identically at baseline and follow-up. Blood pressure was determined as the mean of two measurements taken after 5 minutes of seated rest, and hypertension was defined as systolic blood pressure of 140 mmHg or greater, diastolic blood pressure of 90 mmHg or greater, or self-reported current use of antihypertensive medication. Diabetes mellitus was defined as fasting plasma glucose of 126 mL/dL or more (or ≥200 mL/dL for those who did not fast) or self-report of current use of medications for glucose control. Dyslipidemia was defined as fasting total cholesterol of 240 mg/ dL or greater, fasting low-density lipoprotein cholesterol of 160 mg/dL or greater, fasting high-density lipoprotein cholesterol of 40 mg/dL or less, or self-reported current use of lipid-lowering medications. Atrial fibrillation was defined according to electroencephalographic evidence or participant self-report of a physician diagnosis. 22 Poisson regression was used to calculate age-, race-, and sex-specific incidence rates (proportion of participants free of a risk factor at baseline who had risk factor at follow-up) and black:white incidence ratios. Age was considered in strata of 45 to 54, 55 to 64, 65 to 74, and 75 and older at baseline. Estimates were provided separately for men and women. Age-by-race interaction terms were calculated and considered significant at a = .10.
RESULTS
The description of the population is provided in Table 1 . The median time between in-person assessments was 9.5 years (interdecile range 8.4-10.0 years).
Over follow-up, 2,278 of 5,537 (41%, 95% confidence interval (CI) = 40-42%) of participants who were normotensive at baseline developed hypertension. Figure 1A shows little age-related difference in the incidence of hypertension for white men, black men, or black women (P ≥ .68), with an average (across age strata) incidence of 38% (95% CI = 36-41%), 48% (95% CI = 43-52%) and 54% (95% CI = 51-59%), respectively. In contrast, the incidence of hypertension in white women was 27% (95% CI = 23-33%) for aged 45 to 54 and 40% (95% CI = 33-48%) for aged 75 and older. Figure 1B shows that risk of incident hypertension was 1.24 (95% CI = 1.12-1.37) times as great in black men as in white men, with no age-related differences (P = .98). By contrast, the increasing incidence in white women contributed to an age difference in the black-to-white risk of incident hypertension (P = .08). The risk of incident hypertension was 1.93 (95% CI = 1.55-2.41) times as high in black women aged 45 to 54 as in their white counterparts, diminishing to a 1.18 (95% CI = 0.84-1.65) times as high in those aged 75 and older.
Of the 8,806 participants without baseline diabetes mellitus, 1,279 (15%, 95% CI = 14-15%) developed diabetes mellitus. Figure 2A shows a relatively constant agerelated decline in incident diabetes mellitus, with incidence rates in those aged 45 to 54 of approximately 25% in blacks and 14% in whites and in those aged 75 and older of 14% in blacks and 9% in whites. There was no evidence of an age-related change in the black-to-white relative risk of incident diabetes mellitus for men (P = .64) or women (P = .11) ( Figure 2B ). Overall, black men were 1.52 (95% CI = 1.31-1.78) times as likely, and black women were 2.14 (95% CI = 1.86-2.46) times as likely to develop diabetes mellitus as their white counterparts.
Of the 9,764 participants who were normolipidemic at baseline, 2,740 (28%, 95% CI = 27-29%) became dyslipidemic during follow-up. For all four race-sex groups, the incidence of dyslipidemia was higher for those aged 55 to 64 and 65 to 74 (~30%) than for those aged 45 to 54 (~20%) or aged 75 and older (~22%) ( Figure 3A) . For The 11% of participants who declined to provide information on income were excluded from calculation of percentage.
A B Figure 1 . (A) Probability of incident hypertension over 10 years according to race and sex, shown across age strata and within age strata, with P-values for equality across age strata for each race-sex stratum. (B) Black-to-white relative risk of incident hypertension according to sex, shown across all age strata and within age strata, with P-values for an equal black-to-white risk of incident hypertension over 10 years.
men, the black-white relative risk (RR) of dyslipidemia increased with age (P = .10) from 1.15 (95% CI = 0.82-1.61) for those aged 45 to 54 to 1.26 (95% CI = 1.06-1.51) for those aged 65 to 74 ( Figure 3B ). Likewise, the black-white RR of incident dyslipidemia increased steadily with age in women, from 0.97 (95% CI = 0.77-1.22) for those aged 45 to 54 to 1.39 (95% CI = 1.00-1.95) for those aged 75 and older. Of 10,677 participants without atrial fibrillation at baseline, 996 (9%, 95% CI = 9-10%) developed atrial fibrillation during follow-up. There was an increasing incidence of atrial fibrillation at older ages in all four race-sex groups (P < .01), with incidences of 2% to 6% at ages 44 to 54 and approximately 11% in blacks and 20% in whites aged 75 and older ( Figure 4A ). There was no evidence of an age-related difference in the likelihood of incident atrial fibrillation for men (P = .29) or women (P = .74), with the risk of incident atrial fibrillation substantially lower for black men (RR = 0.51, 95% CI = 0.42-0.63) and black women (RR = 0.57, 95% CI = 0.47-0.70) than for white men and women (Figure 4B) .
DISCUSSION
Older adults are at a high risk of incident cardiovascular risk factors. Across the age strata from 45 to 54 to 75 and older, there were stable (for white men, black men, and black women) or increasing (for white women) incidence rates of hypertension. Likewise, incidence rates increased for all race-sex strata, albeit more rapidly for whites than blacks. These data suggest that clinical management to prevent development of hypertension and atrial fibrillation should continue into the oldest age groups. In contrast, incidence of diabetes mellitus decreased with increasing age, although even above age 75, the incidence of diabetes mellitus over a 10-year follow-up period was 15% in black men and 11% in black women (vs 10% in white men and 8% in white women). Hence, even at the oldest ages, there is substantial risk of the development of diabetes mellitus, particularly for blacks. The incidence of dyslipidemia was lower for those aged 45 to 54 (~20%) than for those aged 54 to 64 or 65 to 74 (~30%), although this incidence decreased to "only" 22% for those aged 75 and older. The reasons for this increasing-thendecreasing pattern of dyslipidemia incidence are not known but could be selective mortality in the oldest age group for those with dyslipidemia. Nevertheless, for any of the age strata, there was a at least a one-in-five risk of the development of dyslipidemia. In summary, the risk of the development of new risk factors remains high, even in those in the oldest age strata.
In addition to providing a description of the incidence rates, these data provide insights into racial disparities in incidence or risk factors. It was previously demonstrated that as much as 40% of the black-white difference in A B Figure 2 . (A) Probability of incident diabetes mellitus over 10 years according to race and sex, shown across age strata and within age strata, with P-values for equality across age strata for each race-sex stratum. (B) Black-to-white relative risk of incident diabetes mellitus according to sex, shown across all age strata and within age strata, with P-values for an equal black-towhite risk of incident hypertension over 10 years. The upper limit of the 95% confidence interval for women aged 75 and older was 6.9.
stroke risk can be attributed to the higher prevalence and severity of "traditional" risk factors in blacks. 4 It is likely that a higher prevalence of risk factors in blacks is because of a higher incidence in blacks. This analysis found large racial disparities in incident hypertension, diabetes mellitus, and dyslipidemia extending into the oldest age strata. Disparities in onset of new risk factors were greatest for hypertension and diabetes mellitus in women. Findings suggest that aggressive primordial prevention efforts may be warranted even in older adults and that interventions specifically targeted at black Americans, especially women, are needed. The goal of this article was to provide a broad overview of black-white differences in the incidence of a spectrum of risk factors, with a detailed analysis of contributors to individual risk factors in subsequent reports (the "risk factors for the incident risk factors").
Hypertension is one of the most-potent risk factors for stroke and heart disease, present in more than 50% of adult whites and more than 70% of adult blacks. 10, 23 These disparities in prevalence are a large contributor to the racial disparities in CVD. 3, 4 Although it is appropriate to focus on blood pressure control, the data reported herein suggest that the high incidence of hypertension extends into the oldest age strata (with increasing risk of incident hypertension at older ages in white women); that there is a 24% greater incidence in black than white men; and that there is an age-related interaction in women, with black women aged 45 to 54 having a 93% higher risk than white women of the same age. Collectively, these findings indicate a substantial increase in the burden of prevalent hypertension with increasing age, as well as an ever-growing magnitude in the racial disparity in this prevalence. Preventing the development of hypertension is critical to risk reduction, because even with treatment providing ideal blood pressure control, there is a substantially greater risk of stroke than in those with ideal blood pressure in the absence of treatment. 24 Hence, although the importance of controlling blood pressure levels of individuals with hypertension cannot be discounted, these findings show that primordial prevention is essential throughout the age span, including in the oldest-old adults.
Largely because the risk of incident hypertension increases with age in white women, in women there was a declining black-to-white relative risk of incident hypertension with increasing age (P = .09) but with the disparity still significant for ages 65 to 74. This declining pattern in women is consistent with previous reports that have suggested that the magnitude of the black-white disparity in the incidence of hypertension may be smaller at older ages. Data from the National Health and Nutrition Examination Survey (NHANES) I Epidemiological Follow-up Study showed that the black-to-white incidence ratio for incident hypertension approximately a decade later was 2.3 for men and 2.8 for women aged 25 to 34, 1.5 for men and 1.8 for women aged 35 to 54, and 1.10 for men and 1.00 for women aged 55 and older. 16 Likewise, the Multiethnic Study of Atherosclerosis reported that the sex-adjusted black-to-white RR of incident hypertension declined from A B Figure 3 . (A) Probability of incident dyslipidemia over 10 years according to race and sex, shown across age strata and within age strata, with P-values for equality across age strata for each race-sex stratum. (B) Black-to-white relative risk of incident dyslipidemia according to sex, shown across all age strata and within age strata, with P-values for an equal black-to-white risk of incident hypertension over 10 years. approximately 3.0 at age 45 to 1.5 at age 70 but then fell rapidly so that there was no disparity by age 80. 25 By contrast, data from REGARDS showed a consistent black-towhite RR of incident hypertension in men across age strata, with no evidence of a decline. Taken together, these studies support that primordial prevention of hypertension is essential for women at least through age 65 to 74 and in men of all ages.
The black-to-white disparity in incident diabetes mellitus was substantially larger than that for hypertension, with black men having a 52% higher risk and black women a 114% higher risk than whites. Unlike hypertension, this disparity was consistent across age groups. Underlying this consistent black-to-white RR of diabetes mellitus was a consistent pattern of falling incidence of diabetes mellitus with increasing age in all four race-sex strata. Hence, although the lower incidence of diabetes mellitus in elderly adults may imply that primordial prevention of diabetes mellitus is less important in elderly adults, the relatively constant black-to-white RR of incident diabetes mellitus implies a relatively constant effect on the black-white disparity across the age spectrum.
Several previous reports have documented the higher incidence of diabetes mellitus in black than white adults. Data from the Nurses' Health Study showed a black-towhite 20-year age-adjusted RR of incident diabetes mellitus identical to that observed here (2.18, 95% CI = 1.82-2.61). 26 Estimates from Centers for Medicare and Medicaid Services administrative data show a blackto-white RR of incident diabetes mellitus ranging from 1.52 to 1.60 between 1994 and 2001. 27 To the knowledge of the authors of the current study, only the NHANES I Epidemiological Follow-up Study has provided age-specific estimates of the incidence of diabetes mellitus, and similar to the current findings, it showed a lack of age-related differences. Collectively, these data suggest that, for men and women, there is no upper age above which a focus on primordial prevention is not important to reduce the racial disparities in diabetes mellitus.
The current study found that racial disparities in the risk of incident dyslipidemia were less than with hypertension and diabetes mellitus but also found an increasing pattern with age for men and women. No studies on the racial disparities in the incidence of dyslipidemia were found, and articles on disparities in the prevalence are sparse. Specifically, there were only minor black-white disparities in low-density lipoprotein cholesterol of 160 and higher in NHANES III (29.1% vs 26.3%) or NHANES 1999 to 2004 (24.3% vs 25.8%). 28 The Multiethnic Study of Atherosclerosis 29 and data from Kaiser Permanente of Northern California showed little evidence of disparities in the prevalence of lipids. 30 Furthermore, approaches to primordial prevention of dyslipidemia in adults are sparse and require further development. Nevertheless, these results suggest that efforts focused on primordial prevention of incident dyslipidemia for all adult men and for older adult women (aged ≥55) could result in some reduction in the racial disparity in CVD mortality.
A B Figure 4 . (A) Probability of incident atrial fibrillation over 10 years according to race and sex, shown across age strata and within age strata, with P-values for equality across age strata for each race-sex stratum. (B) Black-to-white relative risk of incident atrial fibrillation according to sex, shown across all age strata and within age strata, with P-values for an equal black-towhite risk of incident hypertension over 10 years.
These findings of incident atrial fibrillation according to race were similar to the sparse literature on black-white differences in prevalence. Existing findings have been extended by reporting age differences in incidence according to race, a topic not previously reported to the knowledge of the authors. A meta-analysis of nine studies estimated that the odds of prevalent atrial fibrillation were 49% lower in blacks than whites, 31 and only one report was identified that presented the hazard of incident atrial fibrillation in a population aged 65 and older, reporting a black-white hazard ratio of 0.47 (95% CI = 0.22-1.01). 32 The current findings are consistent with this literature, showing a 49% lower incidence of atrial fibrillation in black than white men and a 41% lower risk in black than white women, with no evidence of an age-related difference in these risks. These relatively constant racial disparities were a product of steadily increasing incidence of atrial fibrillation with age in all four race-sex groups. Although the incidence of atrial fibrillation was small, approximately 10% of the population developed the condition, underscoring the need to consider primordial prevention. The paradox of lower rates of atrial fibrillation in blacks, despite blacks having more risk factors, remains. [33] [34] [35] [36] Limitations of this analysis require consideration. There are no clinical trial data documenting that better prevention of risk factors in blacks will reduce disparities in cardiovascular events, although strong epidemiological data suggest that incident disease would be reduced if the population prevalence of risk factors in blacks was smaller. Not all major CVD risk factors were considered in this report. Smoking is one of the most powerful risk factors for CVD but was not included because smoking initiation after age 30 is uncommon. 37 Like all other reports of incident risk factors discussed herein, a weakness of this report is that bias might emanate from exclusion of participants who died or became too ill to participate in the second assessment. These nonparticipants would have most likely had higher rates of incident risk factors, so it is likely that estimates of incidence are underestimated, but unless this effect was differential according to race, it would not alter estimates of racial disparities in incidence. An attempt was made to minimize this shortcoming by limiting the assessment to risk factors with low short-term mortality and morbidity. There were participants with prevalent risk factors at baseline who were classified as being free of the risk factor at follow-up; this represented only a small group for hypertension and diabetes mellitus but a larger group for dyslipidemia and atrial fibrillation (data not shown). It is possible that participants who become free of a risk factor have controlled their conditions through lifestyle changes such as diet, weight-loss, and physical activity, although it is also possible that these changes resulted from misreporting of medication use at baseline or follow-up. Finally, it is likely that the factors contributing to greater risk of hypertension, diabetes mellitus, dyslipidemia, and atrial fibrillation differ, and it is also possible that there are geographic differences confounding the likelihood of incident risk factors. 38 As such, a thorough assessment of the "risk factors for these risk factors" is beyond the scope of this work and will be addressed in subsequent publications.
There are several strengths of this report. The greatest strength is the sizable study population, the high follow-up rates of the cohort, and the number of years between baseline and the second assessment. Appropriate and consistent methods were used to assess risk factors at the two visits.
In conclusion, a high incidence of CVD risk factors over 9.5 years of follow-up was found in individuals aged 45 and older, finding that older adults remain at high risk of incident CVD risk factors. With the exception of incident atrial fibrillation, this incidence was higher in blacks than whites. This study supports aggressive primordial prevention efforts for all cardiovascular risk factors in middle-aged and older adults, especially for black Americans. These data suggest that to reduce black-white disparities in cardiovascular disease, primordial prevention of risk factors needs to be thought of as an activity not just for the young but extending into the oldest age stratum. Efforts are under way to assess the contributors to the racial disparity in hypertension, diabetes mellitus, and dyslipidemia.
